Document is current
Any future updates will be listed below
-
Authors
Tang, Minhong
Crown, John
Duffy, Michael J.
-
Funding
Funding for this research was provided by:
Cancer Clinical Research Trust
University College Dublin
- License Information
-
More Information
Article History
Received: 27 October 2024
Accepted: 30 December 2024
First Online: 28 January 2025
Declarations
:
: Not applicable.
: Not applicable.
: Not applicable.
: MJD and MT: no conflict of interest to disclose. JC, Research funding (to institution): Eisai, Puma Biotechnology, Roche, Boehringer Ingelheim; Employment: OncoMark, Ltd.; Honoraria: Eisai, Puma Biotechnology; MSD Oncology, Pfizer, G1 Therapeutics; Novartis; Speaker’s Bureau: Boehringer Ingelheim, Genomic Health, Roche, Pfizer; Shares: OncoMark Ltd; Travel and accommodation expenses: Pfizer, MSD, Abbvie, Astrazeneca and Novartis.
